February 18, 2025 2:57 PM

Combination immunotherapy shows promise in treating advanced skin cancer

A combination immunotherapy has demonstrated the potential to cure a majority of patients with advanced melanoma that has spread to the brain, according to a seven-year follow-up from a clinical trial. The findings, published in The Lancet Oncology, indicate that more than 50% of patients who received combination immunotherapy as a first-line treatment achieved long-term disease control. Currently, patients with melanoma brain metastases, which affect 30-40% of those with Stage 4 melanoma, have...